GAMMA Investing
ACHV icon

GAMMA Investing’s Achieve Life Sciences ACHV Stock Holding History

GAMMA Investing’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.56K Buy
+811
New +$5.8K ﹤0.01% 3543

Other funds holding ACHV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Manchester Financial
Manchester Financial Westlake Village, California $565M AUM 15.04% 1-Year Est. Return
Prospera Financial Services
Prospera Financial Services Dallas, Texas $7.73B AUM 29.41% 1-Year Est. Return
Members Wealth
Members Wealth Media, Pennsylvania $200M AUM 9.84% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

GAMMA Investing's ACHV Position: Q3 2026 in Review

GAMMA Investing opened a new position in Achieve Life Sciences (ACHV) in Q3 2026: 811 shares worth $6.56K. The stake represents ﹤0.01% of the portfolio and ranks #3543 among its holdings.

33 funds tracked by Wall St. Rank hold ACHV as of Q3 2026.

  • GAMMA Investing held 811 shares of Achieve Life Sciences worth $6.56K as of Q3 2026.
  • Achieve Life Sciences was a new GAMMA Investing position in Q3 2026.
  • Achieve Life Sciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3543 holding.
  • 33 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.